Status: Open Not Enrolling
Investigator: Tetsuo Ashizawa
Study Coordinator:
Phone:
The primary purpose of this study is to compare the efficacy of BHV-4157 (Troriluzole) 140 milligrams (mg) once daily versus placebo after 8 weeks of treatment in subjects with spinocerebellar ataxia (SCA). ... Read more >